Connect Biopharma Holdings Limited (CNTB) vs Oncolytics Biotech Inc. (ONCY)
A side-by-side comparison of Connect Biopharma Holdings Limited and Oncolytics Biotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.96HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
ONCY
Oncolytics Biotech Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — CNTB vs ONCY
growth of $100 · dividends reinvested · last 6yCNTB -95.1% (-39.6%/yr)ONCY -80.9% (-24.1%/yr)ONCY compounded faster over this window
CNTB ONCY
CNTB vs ONCY: by the numbers
- •CNTB is the larger company ($61M vs $60M market cap).
- •Both run net losses; ONCY's is the smaller (0.00% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | ONCY |
|---|---|---|
| P/B ratio | 2.25 | N/A |
Profitability
| Metric | CNTB | ONCY |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -90740.62% | 0.00% |
| Net margin | -86687.50% | 0.00% |
| ROE | -132.16% | N/A |
| ROIC | -136.77% | -1235.48% |
Growth (annualized)
| Metric | CNTB | ONCY |
|---|---|---|
| Total return CAGR (5Y) | -47.22% | -21.00% |
Frequently asked
- How have CNTB and ONCY total returns compared?
- Over the past 5 years, CNTB delivered -47.22% and ONCY delivered -21.00% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.